WALDEN UNIVERSITY – NURS 6630
PSYCHOPHARMACOLOGIC APPROACHES TO
TREATMENT OF PSYCHOPATHOLOGY MIDTERM –
QUESTIONS AND ANSWERS | 2026/2027 LATEST
UPDATE
SECTION 1: NEUROBIOLOGY, NEUROTRANSMISSION & PSYCHOPHARMACOLOGY
FOUNDATIONS
Questions 1–15
1. Which cellular event directly triggers the release of neurotransmitter from a
presynaptic terminal?
A) Sodium leaving the postsynaptic neuron
B) Calcium entering the presynaptic terminal
C) Chloride entering the synaptic cleft
D) Potassium entering the nucleus
Correct Answer: Calcium entering the presynaptic terminal
Rationale: Arrival of an action potential opens voltage-gated calcium channels in the
presynaptic terminal. Calcium influx initiates fusion of synaptic vesicles with the presynaptic
membrane and neurotransmitter release. Sodium and potassium participate in membrane
excitability, while chloride is primarily involved in postsynaptic inhibition rather than
vesicular release.
2. What is the principal function of a neurotransmitter receptor located on the
postsynaptic membrane?
A) It converts a chemical signal into a cellular response
B) It permanently stores neurotransmitter
C) It synthesizes DNA
D) It eliminates the blood-brain barrier
Correct Answer: It converts a chemical signal into a cellular response
Rationale: Postsynaptic receptors recognize neurotransmitters and initiate intracellular
signaling that changes neuronal activity. Depending on receptor type, the response may be
,excitatory, inhibitory, or modulatory. Receptors do not permanently store neurotransmitters
or synthesize DNA, and they do not eliminate the blood-brain barrier.
3. Which neurotransmitter is most directly associated with the reward pathway and
psychotic symptoms when dopaminergic activity is excessive in the mesolimbic
pathway?
A) GABA
B) Glutamate
C) Dopamine
D) Acetylcholine
Correct Answer: Dopamine
Rationale: Dopamine is central to several neural pathways involved in motivation, cognition,
movement, and psychosis. Increased mesolimbic dopamine activity is associated with
positive symptoms such as hallucinations and delusions. GABA and glutamate have
important regulatory roles, while acetylcholine is involved in cognition and parasympathetic
signaling.
4. A medication that binds to a receptor and produces the same type of response as the
endogenous neurotransmitter is best classified as what?
A) Antagonist
B) Inverse agonist
C) Reuptake inhibitor
D) Agonist
Correct Answer: Agonist
Rationale: An agonist binds to a receptor and activates it, mimicking or enhancing the action
of an endogenous ligand. An antagonist binds without producing the receptor response and
blocks activation. Reuptake inhibitors work at transporter proteins, while inverse agonists
produce an effect opposite to constitutive receptor activity.
5. Which pharmacokinetic process describes chemical modification of a medication,
often occurring in the liver?
A) Absorption
B) Metabolism
C) Distribution
D) Elimination
Correct Answer: Metabolism
,Rationale: Metabolism involves enzymatic modification of medications into metabolites,
frequently through hepatic cytochrome P450 pathways. Absorption concerns movement into
systemic circulation, distribution concerns movement throughout tissues, and elimination
involves removal of the drug or metabolites from the body. Metabolic activity can
substantially alter medication concentrations.
6. A PMHNP explains that a medication's half-life refers to which characteristic?
A) The time required for the medication to reach its peak effect
B) The percentage absorbed after administration
C) The time required for plasma concentration to decrease by half
D) The amount of medication bound to protein
Correct Answer: The time required for plasma concentration to decrease by half
Rationale: Half-life is the time needed for the plasma concentration of a medication to fall by
50%. It influences dosing intervals and the time required to reach steady state or clear a
medication. Peak concentration, bioavailability, and protein binding are separate
pharmacokinetic characteristics.
7. Which receptor type is directly linked to an intracellular signaling pathway through a
G protein?
A) Ligand-gated ion channel
B) Voltage-gated calcium channel
C) Nuclear receptor
D) G-protein-coupled receptor
Correct Answer: G-protein-coupled receptor
Rationale: G-protein-coupled receptors activate intracellular second-messenger pathways
through G proteins. Their effects generally occur more slowly than direct ion-channel effects
but can produce amplification and prolonged signaling. Ligand-gated channels directly alter
ion flow, while nuclear receptors regulate gene transcription.
8. What is the primary purpose of the blood-brain barrier in psychopharmacology?
A) To prevent all medications from entering neural tissue
B) To regulate movement of substances between blood and brain tissue
C) To increase neurotransmitter production
D) To eliminate hepatic metabolism
Correct Answer: To regulate movement of substances between blood and brain tissue
, Rationale: The blood-brain barrier selectively controls movement of substances into the
central nervous system. Lipid solubility, molecular size, transport mechanisms, and protein
binding influence whether medications cross it. The barrier does not prevent every
medication from entering the brain, nor does it control hepatic metabolism.
9. Which statement best describes pharmacodynamics?
A) It describes what the body does to the medication
B) It describes medication absorption exclusively
C) It describes what the medication does to the body
D) It describes renal filtration only
Correct Answer: It describes what the medication does to the body
Rationale: Pharmacodynamics concerns the relationship between drug concentration and
biological effect, including receptor binding, signal transduction, efficacy, and adverse
effects. Pharmacokinetics describes what the body does to the medication through
absorption, distribution, metabolism, and elimination. Renal filtration is one component of
pharmacokinetic elimination.
10. Which neurotransmitter generally provides the major inhibitory influence within the
central nervous system?
A) GABA
B) Dopamine
C) Glutamate
D) Norepinephrine
Correct Answer: GABA
Rationale: Gamma-aminobutyric acid, or GABA, is the major inhibitory neurotransmitter in
the central nervous system. Activation of GABA receptors generally decreases neuronal
excitability. Glutamate is the major excitatory neurotransmitter, while dopamine and
norepinephrine are important modulatory neurotransmitters involved in cognition, mood,
motivation, and arousal.
11. A medication has a narrow therapeutic index. What does this characteristic imply for
clinical management?
A) Therapeutic drug monitoring is never necessary
B) The medication has no clinically important adverse effects
C) Small concentration changes may produce toxicity or loss of efficacy
D) The medication is always rapidly eliminated
PSYCHOPHARMACOLOGIC APPROACHES TO
TREATMENT OF PSYCHOPATHOLOGY MIDTERM –
QUESTIONS AND ANSWERS | 2026/2027 LATEST
UPDATE
SECTION 1: NEUROBIOLOGY, NEUROTRANSMISSION & PSYCHOPHARMACOLOGY
FOUNDATIONS
Questions 1–15
1. Which cellular event directly triggers the release of neurotransmitter from a
presynaptic terminal?
A) Sodium leaving the postsynaptic neuron
B) Calcium entering the presynaptic terminal
C) Chloride entering the synaptic cleft
D) Potassium entering the nucleus
Correct Answer: Calcium entering the presynaptic terminal
Rationale: Arrival of an action potential opens voltage-gated calcium channels in the
presynaptic terminal. Calcium influx initiates fusion of synaptic vesicles with the presynaptic
membrane and neurotransmitter release. Sodium and potassium participate in membrane
excitability, while chloride is primarily involved in postsynaptic inhibition rather than
vesicular release.
2. What is the principal function of a neurotransmitter receptor located on the
postsynaptic membrane?
A) It converts a chemical signal into a cellular response
B) It permanently stores neurotransmitter
C) It synthesizes DNA
D) It eliminates the blood-brain barrier
Correct Answer: It converts a chemical signal into a cellular response
Rationale: Postsynaptic receptors recognize neurotransmitters and initiate intracellular
signaling that changes neuronal activity. Depending on receptor type, the response may be
,excitatory, inhibitory, or modulatory. Receptors do not permanently store neurotransmitters
or synthesize DNA, and they do not eliminate the blood-brain barrier.
3. Which neurotransmitter is most directly associated with the reward pathway and
psychotic symptoms when dopaminergic activity is excessive in the mesolimbic
pathway?
A) GABA
B) Glutamate
C) Dopamine
D) Acetylcholine
Correct Answer: Dopamine
Rationale: Dopamine is central to several neural pathways involved in motivation, cognition,
movement, and psychosis. Increased mesolimbic dopamine activity is associated with
positive symptoms such as hallucinations and delusions. GABA and glutamate have
important regulatory roles, while acetylcholine is involved in cognition and parasympathetic
signaling.
4. A medication that binds to a receptor and produces the same type of response as the
endogenous neurotransmitter is best classified as what?
A) Antagonist
B) Inverse agonist
C) Reuptake inhibitor
D) Agonist
Correct Answer: Agonist
Rationale: An agonist binds to a receptor and activates it, mimicking or enhancing the action
of an endogenous ligand. An antagonist binds without producing the receptor response and
blocks activation. Reuptake inhibitors work at transporter proteins, while inverse agonists
produce an effect opposite to constitutive receptor activity.
5. Which pharmacokinetic process describes chemical modification of a medication,
often occurring in the liver?
A) Absorption
B) Metabolism
C) Distribution
D) Elimination
Correct Answer: Metabolism
,Rationale: Metabolism involves enzymatic modification of medications into metabolites,
frequently through hepatic cytochrome P450 pathways. Absorption concerns movement into
systemic circulation, distribution concerns movement throughout tissues, and elimination
involves removal of the drug or metabolites from the body. Metabolic activity can
substantially alter medication concentrations.
6. A PMHNP explains that a medication's half-life refers to which characteristic?
A) The time required for the medication to reach its peak effect
B) The percentage absorbed after administration
C) The time required for plasma concentration to decrease by half
D) The amount of medication bound to protein
Correct Answer: The time required for plasma concentration to decrease by half
Rationale: Half-life is the time needed for the plasma concentration of a medication to fall by
50%. It influences dosing intervals and the time required to reach steady state or clear a
medication. Peak concentration, bioavailability, and protein binding are separate
pharmacokinetic characteristics.
7. Which receptor type is directly linked to an intracellular signaling pathway through a
G protein?
A) Ligand-gated ion channel
B) Voltage-gated calcium channel
C) Nuclear receptor
D) G-protein-coupled receptor
Correct Answer: G-protein-coupled receptor
Rationale: G-protein-coupled receptors activate intracellular second-messenger pathways
through G proteins. Their effects generally occur more slowly than direct ion-channel effects
but can produce amplification and prolonged signaling. Ligand-gated channels directly alter
ion flow, while nuclear receptors regulate gene transcription.
8. What is the primary purpose of the blood-brain barrier in psychopharmacology?
A) To prevent all medications from entering neural tissue
B) To regulate movement of substances between blood and brain tissue
C) To increase neurotransmitter production
D) To eliminate hepatic metabolism
Correct Answer: To regulate movement of substances between blood and brain tissue
, Rationale: The blood-brain barrier selectively controls movement of substances into the
central nervous system. Lipid solubility, molecular size, transport mechanisms, and protein
binding influence whether medications cross it. The barrier does not prevent every
medication from entering the brain, nor does it control hepatic metabolism.
9. Which statement best describes pharmacodynamics?
A) It describes what the body does to the medication
B) It describes medication absorption exclusively
C) It describes what the medication does to the body
D) It describes renal filtration only
Correct Answer: It describes what the medication does to the body
Rationale: Pharmacodynamics concerns the relationship between drug concentration and
biological effect, including receptor binding, signal transduction, efficacy, and adverse
effects. Pharmacokinetics describes what the body does to the medication through
absorption, distribution, metabolism, and elimination. Renal filtration is one component of
pharmacokinetic elimination.
10. Which neurotransmitter generally provides the major inhibitory influence within the
central nervous system?
A) GABA
B) Dopamine
C) Glutamate
D) Norepinephrine
Correct Answer: GABA
Rationale: Gamma-aminobutyric acid, or GABA, is the major inhibitory neurotransmitter in
the central nervous system. Activation of GABA receptors generally decreases neuronal
excitability. Glutamate is the major excitatory neurotransmitter, while dopamine and
norepinephrine are important modulatory neurotransmitters involved in cognition, mood,
motivation, and arousal.
11. A medication has a narrow therapeutic index. What does this characteristic imply for
clinical management?
A) Therapeutic drug monitoring is never necessary
B) The medication has no clinically important adverse effects
C) Small concentration changes may produce toxicity or loss of efficacy
D) The medication is always rapidly eliminated
